Atrial arrhythmias and special circumstances

Canadian Journal of Cardiology

Volumn 21, Issue SUPPL. B, 2005, Pages

  Harris, Louise ^a,d   Cow, Robert M ^b   Kirsh, Joel A ^a   Klein, George J ^c   Siu, Samuel C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Atrial arrhythmias; Atrial arrhythmias in a pediatric population; Congenital heart disease; Hypertrophic cardiomyopathy; Intra atrial reentrant tachycardia; Pregnancy; Wolff Parkinson White syndrome

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DISOPYRAMIDE; FLECAINIDE; HEPARIN; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHY; CATHETER ABLATION; CONFERENCE PAPER; CONGENITAL HEART DISEASE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART SURGERY; HUMAN; MEDICAL SOCIETY; PREGNANCY; PREVALENCE; WOLFF PARKINSON WHITE SYNDROME;

ATRIAL FIBRILLATION; ATRIAL FLUTTER; HUMANS; PRACTICE GUIDELINES;

EID: 34247536859     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (116)

1. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-713.
2. Favale S, Pappone C, Nacci F, Fino F, Resta F, Dicandia CD. Sudden death due to atrial fibrillation in hypertrophic cardiomyopathy: A predictable event in a young patient. Pacing Clin Electrophysiol 2003;26:637-9.
3. Boriani G, Rapezzi C, Biffi M, Branzi A, Spirito P. Atrial fibrillation precipitating sustained ventricular tachycardia in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 2002;13:954.
4. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001;104:2517-24.
5. Doi Y, Kitaoka H. Hypertrophic cardiomyopathy in the elderly: Significance of atrial fibrillation. J Cardiol 2001;37(Suppl 1):133-8.
6. Lopez Gil M, Arribas F, Cosio FG. Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy. Europace 2000;2:327-32.
7. Suzuki M, Hirayama T, Marumoto K, Okayama H, Iwata T. Paroxysmal atrial fibrillation as a cause of potentially lethal ventricular arrhythmia with myocardial ischemia in hypertrophic cardiomyopathy - a case report. Angiology 1998;49:653-7.
8. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. Jpn Circ J 1995;59:329-36.
9. Albanest Filho FM, Girardi JM, Castier MB, Ginefra P. [Influence of atrial fibrillation in the natural history of hypertrophic cardiomyopathy.] Arq Bras Cardiol 1994;62:337-41.
10. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
11. Maron BJ, Olivotto I, Bellone P, et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:301-7.
12. McKenna WJ, Harris L, Rowland E, et al. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol 1984;54:802-10.
13. Sugrue DD, Dickie S, Myers MJ, Lavender JP, McKenna WJ. Effect of amiodarone on left ventricular ejection and filling in hypertrophic cardiomyopathy as assessed by radionuclide angiography. Am J Cardiol 1984;54:1054-8.
14. Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study. J Am Coll Cardiol 1990;15:1279-85.
15. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-85.
16. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001;104:2118-50.
17. Pollick C, Kimball B, Henderson M, Wigle ED. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol 1988;62:1248-51.
18. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002;287:1308-20.
19. Wellens HJ, Durrer D. Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation. Am J Cardiol 1974;34:777-82.
20. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979;301:1080-5.
21. Hamada T, Hiraki T, Ikeda H, et al. Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 2002;13:223-9.
22. Gulamhusein S, Ko P, Carruthers SG, Klein GJ. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation 1982;65:348-54.
23. Kuga K, Yamaguchi I, Sugishita Y. Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome. Jpn Circ J 1999;63:189-95.
24. Soult JA, Munoz M, Lopez JD, Romero A, Santos J, Tovaruela A. Efficacy and safety of intravenous amiodarone for short-term treatment of paroxysmal supraventricular tachycardia in children. Pediatr Cardiol 1995;16:16-9.
25. Boriani G, Biffi M, Frabetti L, et al. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J 1996;131:1214-6.
26. Pappone C, Santinelli V, Manguso F, et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med 2003;349:1803-11.
27. Pappone C, Santinelli V, Rosanio S, et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: Results from a large prospective long-term follow-up study. J Am Coll Cardiol 2003;41:239-44.
28. Todd DM, Klein GJ, Krahn AD, Skanes AC, Yee R. Asymptomatic Wolff-Parkinson-White syndrome: Is it time to revisit guidelines? J Am Coll Cardiol 2003;41:245-8.
29. Mendelsohn CL. Disorders of the heartbeat during pregnancy. Am J Obstet Gynecol 1956;72:1268-301.
30. Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:2789-94.
31. Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003;91:1382-5.
32. Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: A correctable cause of "idiopathic" atrial fibrillation. Am J Cardiol 1979;44:9-12.
33. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231-66.
34. Page RL. Treatment of arrhythmias during pregnancy. Am Heart J 1995;130:871-6.
35. Chow T, Galvin J, McGovern B. Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 1998;82:58I-62I.
36. Lownes HE, Ives TJ. Mexiletine use in pregnancy and lactation. Am J Obstet Gynecol 1987;157:446-7.
37. Wagner X, Jouglard J, Moulin M, Miller AM, Petitjean J, Pisapia A. Coadministration of flecainide acetate and sotalol during pregnancy: Lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J 1990;119:700-2.
38. Ovadia M, Brito M, Hoyer GL, Marcus FI. Human experience with amiodarone in the embryonic period. Am J Cardiol 1994;73:316-7.
39. Magee LA, Downar E, Sermer M, Boulton BC, Allen LC, Koren G. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 1995;172:1307-11.
40. Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 2001;24:116-30.
41. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003;42:1493-531.
42. Leung CY, Brodsky MA. Cardiac arrhythmias and pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac Problems in Pregnancy. New York: Wiley-Liss, 1998:155-74.
43. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122S-31S.
44. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41.
45. Ozanne P, Linderkamp O, Miller FC, Meiselman HJ. Erythrocyte aggregation during normal pregnancy. Am J Obstet Gynecol 1983;147:576-83.
46. Rodefeld MD, Bromberg BI, Schuessler RB, Boineau JP, Cox JL, Huddleston CB. Atrial flutter after lateral tunnel construction in the modified Fontan operation: A canine model. J Thorac Cardiovasc Surg 1996;111:514-26.
47. Gandhi SK, Bromberg BI, Rodefeld MD, et al. Spontaneous atrial flutter in a chronic canine model of the modified Fontan operation. J Am Coll Cardiol 1997;30:1095-103.
48. Love BA, Collins KK, Walsh EP, Triedman JK. Electroanatomic characterization of conduction barriers in sinus/atrially paced rhythm and association with intra-atrial reentrant tachycardia circuits following congenital heart disease surgery. J Cardiovasc Electrophysiol 2001;12:17-25.
49. Akar JG, Kok LC, Haines DE, DiMarco JP, Mounsey JP. Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease. J Am Coll Cardiol 2001;38:377-84.
50. Kirsh JA, Walsh EP, Triedman JK. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol 2002;90:338-40.
51. Muller GI, Deal BJ, Strasburger JF, Benson DW Jr. Electrocardiographic features of atrial tachycardias after operation for congenital heart disease. Am J Cardiol 1993;71:122-4.
52. Gelatt M, Hamilton RM, McCrindle BW, et al. Arrhythmia and mortality after the Mustard procedure: A 30-year single-center experience. J Am Coll Cardiol 1997;29:194-201.
53. Bink-Boelkens MT, Velvis H, van der Heide JJ, Eygelaar A, Hardjowijono RA. Dysrhythmias after atrial surgery in children. Am Heart J 1983;106:125-30.
54. Gelatt M, Hamilton RM, McCrindle BW, et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol 1994;24:1735-41.
55. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation 1995;91:2214-9.
56. Li W, Somerville J, Gibson DG, Henein MY. Effect of atrial flutter on exercise tolerance in patients with grown-up congenital heart (GUCH). Am Heart J 2002;144:173-9.
57. Li W, Somerville J. Atrial flutter in grown-up congenital heart (GUCH) patients. Clinical characteristics of affected population. Int J Cardiol 2000;75:129-37.
58. Garson A Jr, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: A collaborative study of 380 cases. J Am Coll Cardiol 1985;6:871-8.
59. Balling G, Vogt M, Kaemmerer H, Eicken A, Meisner H, Hess J. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 2000;119:745-52.
60. Odegard KC, McGowan FX Jr, Zurakowski D, et al. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: Increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 2003;125:1260-7.
61. Odegard KC, McGowan FX Jr, Dinardo JA, et al. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure. J Thorac Cardiovasc Surg 2002;123:459-65.
62. Feltes TF, Friedman RA. Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. J Am Coll Cardiol 1994;24:1365-70.
63. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 2003;108:1871-909.
64. Beaufort-Krol GC, Bink-Boelkens MT. Effectiveness of sotalol for atrial flutter in children after surgery for congenital heart disease. Am J Cardiol 1997;79:92-4.
65. Beaufort-Krol GC, Bink-Boelkens MT. Sotalol for atrial tachycardias after surgery for congenital heart disease. Pacing Clin Electrophysiol 1997;20:2125-9.
66. Kanter RJ, Garson A Jr. Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease. Pacing Clin Electrophysiol 1997;20:502-11.
67. Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone-associated thyroid dysfunction: Risk factors in adults with congenital heart disease. Circulation 1999;100:149-54.
68. Stephenson EA, Casavant D, Tuzi J, et al. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003;92:871-6.
69. Gallik D, Altamirano J, Singh BN. Restoring sinus rhythm in patients with atrial flutter and fibrillation: Pharmacologic or electrical cardioversion? J Cardiovasc Pharmacol Ther 1997;2:135-44.
70. Silka MJ, Manwill JR, Kron J, McAnulty JH. Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates. Am J Cardiol 1990;65:488-93.
71. Fukushige J, Porter CB, Hayes DL, McGoon MD, Osborn MJ, Vlietstra RE. Antitachycardia pacemaker treatment of postoperative arrhythmias in pediatric patients. Pacing Clin Electrophysiol 1991;14:546-56.
72. Chiu CC, McCrindle BW, Hamilton RM, Griffiths JE, Gow RM. Clinical use of permanent pacemaker for conversion of intraatrial reentry tachycardia in children. Pacing Clin Electrophysiol 2001;24:950-6.
73. Timmermans C, Rodriguez LM, Reuter D, et al. Management of atrial arrhythmias secondary to severe congenital heart disease with the Atrioverter. Pacing Clin Electrophysiol 2000;23:1181-3.
74. Nakagawa H, Shah N, Matsudaira K, et al. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: Isolated channels between scars allow "focal" ablation. Circulation 2001;103:699-709.
75. Collins KK, Love BA, Walsh EP, Saul JP, Epstein MR, Triedman JK. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol 2000;86:969-74.
76. de Groot NM, Schalij MJ, Zeppenfeld K, Blom NA, Van der Velde ET, Van der Wall EE. Voltage and activation mapping: How the recording technique affects the outcome of catheter ablation procedures in patients with congenital heart disease. Circulation 2003;108:2099-106.
77. Triedman JK, Alexander ME, Love BA, et al. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol 2002;39:1827-35.
78. Kanter RJ, Papagiannis J, Carboni MP, Ungerleider RM, Sanders WE, Wharton JM. Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries. J Am Coll Cardiol 2000;35:428-41.
79. Deal BJ, Mavroudis C, Backer CL, Buck SH, Johnsrude C. Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients. Circulation 2002;106:575-9.
80. Mavroudis C, Backer CL, Deal BJ, Johnsrude CL. Fontan conversion to cavopulmonary connection and arrhythmia circuit cryoblation. J Thorac Cardiovasc Surg 1998;115:547-56.
81. Deal BJ, Mavroudis C, Backer CL. Beyond Fontan conversion: Surgical therapy of arrhythmias including patients with associated complex congenital heart disease. Ann Thorac Surg 2003;76:542-53.
82. Vignati G, Crupi G, Vanini V, Iorio FS, Borghi A, Giusti S. Surgical treatment of arrhythmias related to congenital heart diseases. Ann Thorac Surg 2003;75:1194-9.
83. Theodoro DA, Danielson GK, Porter CJ, Warnes CA. Right-sided maze procedure for right atrial arrhythmias in congenital heart disease. Ann Thorac Surg 1998;65:149-53.
84. Kopf GS, Mello DM, Kenney KM, Moltedo J, Rollinson NR, Snyder CS. Intraoperative radiofrequency ablation of the atrium: Effectiveness for treatment of supraventricular tachycardia in congenital heart surgery. Ann Thorac Surg 2002;74:797-804.
85. Radford DJ, Izukawa T. Atrial fibrillation in children. Pediatrics 1977;59:250-6.
86. Casey FA, McCrindle BW, Hamilton RM, Gow RM. Neonatal atrial flutter: Significant early morbidity and excellent long-term prognosis. Am Heart J 1997;133:302-6.
87. Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-11.
88. Tikanoja T, Kirkinen P, Nikolajev K, Eresmaa L, Haring P. Familial atrial fibrillation with fetal onset. Heart 1998;79:195-7.
89. Gillette P, Blair H, Crawford F. Preexcitation syndromes. In: Gillette P, Garson A Jr, eds. Pediatric Arrhythmias: Electrophysiology and Pacing. Philadelphia: WB Saunders Company, 1990:360-79.
90. Belhassen B, Pauzner D, Blieden L, et al. Intrauterine and postnatal atrial fibrillation in the Wolff-Parkinson-White syndrome. Circulation 1982;66:1124-8.
91. Pagis B, Villain E, Hidden-Lucet F, Frank R, Sidi D. Wolff-Parkinson- White syndrome in the child. A case report with associated atrial fibrillation. Arch Pediatr 2003;10:38-41.
92. Paul T, Guccione P, Garson A Jr. Relation of syncope in young patients with Wolff-Parkinson-White syndrome to rapid ventricular response during atrial fibrillation. Am J Cardiol 1990;65:318-21.
93. Bromberg BI, Lindsay BD, Cain ME, Cox JL. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1996;27:690-5.
94. Vignati G, Balla E, Mauri L, Lunati M, Figini A. Clinical and electrophysiologic evolution of the Wolff-Parkinson-White syndrome in children: Impact on approaches to management. Cardiol Young 2000;10:367-75.
95. Miyazaki A, Ichida F, Suzuki Y, Okada T. Long-term follow-up of a child with idiopathic restrictive cardiomyopathy. Heart Vessels Suppl 1990;5:74-6.
96. McKenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC, Deanfield JE. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 1988;11:147-53.
97. Stafford WJ, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;7:701-4.
98. Friedman RA, Moak JP, Garson A Jr. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 1991;18:152-6.
99. Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 1991;68:365-9.
100. Sachdev B, Elliott PM, McKenna WJ. Cardiovascular Complications of Neuromuscular Disorders. 2002;4:171-9.
101. Boriani G, Gallina M, Merlini L, et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: A long-term longitudinal study. Stroke 2003;34:901-8.
102. Stevenson WG, Perloff JK, Weiss JN, Anderson TL. Facioscapulohumeral muscular dystrophy: Evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 1990;15:292-9.
103. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: A multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002;40:1645-52.
104. Collins KK, Thiagarajan RR, Chin C, et al. Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation. J Heart Lung Transplant 2003;22:1126-33.
105. Okubo S, Nagata S, Masuda Y, Kawazoe K, Atobe M, Manabe H. Clinical features of rheumatic heart disease in Bangladesh. Jpn Circ J 1984;48:1345-9.
106. Perry LW, Hung W. Atrial fibrillation and hyperthyroidism in a 14-year-old body. J Pediatr 1971;79:668-71.
107. Iwasaki T, Naka M, Hiramatsu K, et al. Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves' disease. Cardiology 1989;76:10-7.
108. Ueda N, Yoshikawa T, Chihara M, Kawaguchi S, Niinomi Y, Yasaki T. Atrial fibrillation following methylprednisolone pulse therapy. Pediatr Nephrol 1988;2:29-31.
109. Arya KR, Taori GK, Khanna SS. Electrocardiographic manifestations following electric injury. Int J Cardiol 1996;57:100-1.
110. Thornton JR. Atrial fibrillation in healthy non-alcoholic people after an alcoholic binge. Lancet 1984;2:1013-5.
111. Ristic AD, Maisch B, Hufnagel G, et al. Arrhythmias in acute pericarditis. An endomyocardial biopsy study. Herz 2000;25:729-33.
112. Spodick DH. Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. JAMA 1976;235:39-41.
113. Dunnigan A, Benson W Jr, Benditt DG. Atrial flutter in infancy: Diagnosis, clinical features, and treatment. Pediatrics 1985;75:725-9.
114. Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia. Ann Pharmacother 1997;31:1347-59.
115. McNamara RL, Tamariz LJ, Segal JB, Bass EB. Management of atrial fibrillation: Review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 2003;139:1018-33.
116. Snow V, Weiss KB, LeFevre M, et al. Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003;139:1009-17.